Johnson & Johnson has reportedly had early discussions with potential buyers about its Cerenovus line of stroke products. Financial Times broke the news first, quoting multiple anonymous sources familiar with the matter.Read More
Report: Johnson & Johnson wants to sell its stroke business for more than $1B
